JPWO2022071233A1 - - Google Patents

Info

Publication number
JPWO2022071233A1
JPWO2022071233A1 JP2022553959A JP2022553959A JPWO2022071233A1 JP WO2022071233 A1 JPWO2022071233 A1 JP WO2022071233A1 JP 2022553959 A JP2022553959 A JP 2022553959A JP 2022553959 A JP2022553959 A JP 2022553959A JP WO2022071233 A1 JPWO2022071233 A1 JP WO2022071233A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022553959A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022071233A1 publication Critical patent/JPWO2022071233A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
JP2022553959A 2020-09-29 2021-09-27 Pending JPWO2022071233A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020164034 2020-09-29
PCT/JP2021/035417 WO2022071233A1 (ja) 2020-09-29 2021-09-27 優れた保存効力を示す液状医薬組成物

Publications (1)

Publication Number Publication Date
JPWO2022071233A1 true JPWO2022071233A1 (ja) 2022-04-07

Family

ID=80949079

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022553959A Pending JPWO2022071233A1 (ja) 2020-09-29 2021-09-27

Country Status (16)

Country Link
US (1) US20230372315A1 (ja)
EP (1) EP4223295A1 (ja)
JP (1) JPWO2022071233A1 (ja)
KR (1) KR20230084205A (ja)
CN (1) CN116472032A (ja)
AU (1) AU2021354445A1 (ja)
BR (1) BR112023005756A2 (ja)
CA (1) CA3194011A1 (ja)
CL (1) CL2023000871A1 (ja)
CO (1) CO2023003536A2 (ja)
EC (1) ECSP23020965A (ja)
MX (1) MX2023003603A (ja)
PE (1) PE20240109A1 (ja)
TW (1) TW202222347A (ja)
WO (1) WO2022071233A1 (ja)
ZA (1) ZA202303906B (ja)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69127595T2 (de) 1990-07-10 1998-01-22 Ishihara Sangyo Kaisha Diaminotrifluoromethylpyrimidinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Phospholipase-A2-Inhibitoren
IL150965A0 (en) * 2000-01-31 2003-02-12 Ishihara Sangyo Kaisha Therapeutic or preventive agent for digestive system diseases containing a diaminotrifluoromethylpyridine derivative
AU2001228862A1 (en) 2000-02-01 2001-08-14 Ishihara Sangyo Kaisha Ltd. Remedies or preventives for liver diseases containing diaminotrifluoromethylpyridine derivatives
JP4848092B2 (ja) 2000-02-01 2011-12-28 石原産業株式会社 ジアミノトリフルオロメチルピリジン誘導体を含有する肺不全の治療剤又は予防剤
JP5584518B2 (ja) 2009-05-28 2014-09-03 石原産業株式会社 ジアミノトリフルオロメチルピリジン誘導体を含有する抗ショック剤
DE112010003355T5 (de) * 2009-08-21 2012-07-12 Targeted Delivery Technologies Ltd. Veskuläre Formulierungen
US20160193147A1 (en) * 2013-07-31 2016-07-07 Sequessome Technology Holdings Limited Vesicles
CA3092616A1 (en) 2018-03-01 2019-09-06 Ishihara Sangyo Kaisha, Ltd. Pharmaceutical composition with excellent storage stability

Also Published As

Publication number Publication date
BR112023005756A2 (pt) 2023-05-09
ECSP23020965A (es) 2023-04-28
EP4223295A1 (en) 2023-08-09
KR20230084205A (ko) 2023-06-12
CN116472032A (zh) 2023-07-21
WO2022071233A1 (ja) 2022-04-07
CA3194011A1 (en) 2022-04-07
AU2021354445A1 (en) 2023-05-18
CO2023003536A2 (es) 2023-05-29
US20230372315A1 (en) 2023-11-23
ZA202303906B (en) 2024-06-26
CL2023000871A1 (es) 2023-11-10
MX2023003603A (es) 2023-04-05
PE20240109A1 (es) 2024-01-22
TW202222347A (zh) 2022-06-16

Similar Documents

Publication Publication Date Title
BR112023005462A2 (ja)
BR112021014123A2 (ja)
BR112023012656A2 (ja)
BR112022009896A2 (ja)
BR112022024743A2 (ja)
BR112023009656A2 (ja)
BR102021018859A2 (ja)
BR102021015500A2 (ja)
BR112023011738A2 (ja)
BR112023016292A2 (ja)
BR112023004146A2 (ja)
BR112023011539A2 (ja)
BR112023011610A2 (ja)
BR112023008976A2 (ja)
BR112023006729A2 (ja)
BR102021020147A2 (ja)
JPWO2022071233A1 (ja)
BR102021018926A2 (ja)
BR102021018167A2 (ja)
BR102021017576A2 (ja)
BR102021016837A2 (ja)
BR102021016551A2 (ja)
BR102021016375A2 (ja)
BR102021016200A2 (ja)
BR102021016176A2 (ja)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240614